MSL, Hematology – B-Cell Malignancies (OH/MI/KY/IN)

Regeneron Pharmaceuticals, Inc.; United States; Vor Ort; USD 176.000 - 287.000; Vollzeit

Zusammenfassung

Regeneron seeks an Associate Director, Field Medical Affairs (Medical Science Liaison) to exchange scientific data with KOLs, HCPs and researchers and to advocate for Regeneron therapies in B-Cell Malignancies, including NHL and multiple myeloma. The role emphasizes building scientific relationships and driving strategic medical plans.

The position requires 8+ years of experience, a terminal degree, and readiness to travel ~70% across OH, MI, IN and KY, with strong knowledge of clinical trials

Qualifikationen

• Terminal scientific degree required (MD/PharmD/PhD/DNP/DVM).
• 8+ years experience; minimum 4 years in Hematology/Oncology Medical Science Liaison.
• Knowledge of treatment guidelines, clinical research processes, FDA regulations, pharma/compliance.

Aufgaben

• Identify and maintain a list of medical/therapeutic area experts and investigators.
• Establish and maintain relationships with KOLs in Hematologic Malignancies.
• Serve as primary clinical/scientific resource for disease state and products.
• Support investigator-initiated studies and clinical trials concept programs.
• Identify insights on research developments to shape medical strategy.
• Respond to information requests and present clinical data.
• Attend medical conferences and report relevant intelligence.

Kenntnisse

KOL engagement

MSL experience

Hematology knowledge

Ausbildung

MD/PhD/PharmD/DNP/DVM

Jobbeschreibung

Regeneron seeks an Associate Director, Field Medical Affairs (Medical Science Liaison) to exchange scientific data with KOLs, HCPs and researchers and to advocate for Regeneron therapies in B-Cell Malignancies, including NHL and multiple myeloma. The role emphasizes building scientific relationships and driving strategic medical plans.

The position requires 8+ years of experience, a terminal degree, and readiness to travel ~70% across OH, MI, IN and KY, with strong knowledge of clinical trials